as of 03-06-2026 3:56pm EST
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | Boston |
| Market Cap: | 89.9M | IPO Year: | 2020 |
| Target Price: | $7.42 | AVG Volume (30 days): | 138.7K |
| Analyst Decision: | Hold | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.96 | EPS Growth: | 57.06 |
| 52 Week Low/High: | $3.71 - $9.15 | Next Earning Date: | 05-14-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | -18.44% | Revenue Growth (next year): | 4.24% |
| P/E Ratio: | -0.94 | Index: | N/A |
| Free Cash Flow: | -65974000.0 | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Chief Accounting Officer
Avg Cost/Share
$5.24
Shares
130
Total Value
$681.20
Owned After
2,933
SEC Form 4
President, International
Avg Cost/Share
$5.24
Shares
3,573
Total Value
$18,722.52
Owned After
116,297
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$5.24
Shares
10,796
Total Value
$56,571.04
Owned After
203,586
SEC Form 4
Chief Product & Tech. Officer
Avg Cost/Share
$5.45
Shares
2,472
Total Value
$13,472.40
Owned After
196,242
SEC Form 4
Chief Accounting Officer
Avg Cost/Share
$4.85
Shares
384
Total Value
$1,862.40
Owned After
2,933
SEC Form 4
President, International
Avg Cost/Share
$4.85
Shares
3,707
Total Value
$17,978.95
Owned After
116,297
SEC Form 4
Chief Product & Tech. Officer
Avg Cost/Share
$4.85
Shares
6,243
Total Value
$30,278.55
Owned After
196,242
SEC Form 4
Director
Avg Cost/Share
$4.73
Shares
612
Total Value
$2,883.00
Owned After
12
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| McNeice Paul Francis | AMWL | Chief Accounting Officer | Mar 2, 2026 | Sell | $5.24 | 130 | $681.20 | 2,933 | |
| Gotlib Phyllis | AMWL | President, International | Mar 2, 2026 | Sell | $5.24 | 3,573 | $18,722.52 | 116,297 | |
| HIRSCHHORN MARK | AMWL | Chief Financial Officer | Mar 2, 2026 | Sell | $5.24 | 10,796 | $56,571.04 | 203,586 | |
| Zamansky Dmitry | AMWL | Chief Product & Tech. Officer | Mar 2, 2026 | Sell | $5.45 | 2,472 | $13,472.40 | 196,242 | |
| McNeice Paul Francis | AMWL | Chief Accounting Officer | Jan 2, 2026 | Sell | $4.85 | 384 | $1,862.40 | 2,933 | |
| Gotlib Phyllis | AMWL | President, International | Jan 2, 2026 | Sell | $4.85 | 3,707 | $17,978.95 | 116,297 | |
| Zamansky Dmitry | AMWL | Chief Product & Tech. Officer | Jan 2, 2026 | Sell | $4.85 | 6,243 | $30,278.55 | 196,242 | |
| Jackson Deborah C | AMWL | Director | Dec 18, 2025 | Sell | $4.73 | 612 | $2,883.00 | 12 |
SEC 8-K filings with transcript text
Feb 12, 2026 · 100% conf.
1D
+7.11%
$4.73
Act: +22.17%
5D
+6.85%
$4.72
Act: +23.30%
20D
+0.53%
$4.44
8-K
false000139358400013935842026-02-122026-02-12
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 12, 2026
American Well Corporation (Exact name of Registrant as Specified in Its Charter)
Delaware
001-39515
20-5009396
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
75 State Street 26th Floor
Boston, Massachusetts
02109
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 617 204-3500
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.01 Par Value
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On February 12, 2026, American Well Corporation (the "Company") announced its financial results for the fourth quarter and full year ended December 31, 2025. The Company's Earnings Report is furnished as Exhibit 99.1 to this Form 8-K and is incorporated by reference herein. The Company will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/7o2zjx2o/. A webcast replay of the call will be available via webcast shortly after the completion of the call, for approximately 90 days at investors.amwell.com. The information contained in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibits are being filed herewith:
99.1
Earnings Report, dated February 12, 2026, issued by American Well Corporation.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
February 12, 2026
By:
/s/ Anna Nesterova
Anna Nesterova Deputy General Counsel, Head of Legal
Nov 4, 2025
8-K
0001393584false00013935842025-11-042025-11-04
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 04, 2025
American Well Corporation (Exact name of Registrant as Specified in Its Charter)
Delaware
001-39515
20-5009396
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
75 State Street 26th Floor
Boston, Massachusetts
02109
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 617 204-3500
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.01 Par Value
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On November 4, 2025, American Well Corporation (the "Company") announced its financial results for the fiscal quarter ended September 30, 2025. The Company's Earnings Report is furnished as Exhibit 99.1 to this Form 8-K and is incorporated by reference herein.
The Company will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/63sb3bwu. A webcast replay of the call will be available via webcast shortly after the completion of the call, for approximately 90 days at investors.amwell.com.
The information contained in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibit is being filed herewith:
99.1
Earnings Report, dated November 4, 2025, issued by American Well Corporation.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
November 4, 2025
By:
/s/ Anna Nesterova
Anna Nesterova Head of Legal
Aug 5, 2025
8-K
false000139358400013935842025-08-052025-08-05
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 05, 2025
American Well Corporation (Exact name of Registrant as Specified in Its Charter)
Delaware
001-39515
20-5009396
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
75 State Street 26th Floor
Boston, Massachusetts
02109
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 617 204-3500
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.01 Par Value
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On August 5, 2025, American Well Corporation (the "Company") announced its financial results for the fiscal quarter ended June 30, 2025. The Company's Earnings Report is furnished as Exhibit 99.1 to this Form 8-K and is incorporated by reference herein.
The Company will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast replay of the call will be available via webcast shortly after the completion of the call, for approximately 90 days at investors.amwell.com.
The information contained in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibit is being filed herewith:
99.1
Earnings Report, dated August 5, 2025, issued by American Well Corporation.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
August 5, 2025
By:
/s/ Anna Nesterova
Anna Nesterova Head of Legal
See how AMWL stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "AMWL American Well Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.